To menu

TOP > Who we are > Our people > Shinsuke MIYANO, MD, MSc, PhD

Shinsuke MIYANO, MD, MSc, PhD

 As of Octorver 2023

Deputy Director, Division of Global Networking,
Department of Global Network and Partnership


Area of expertise

Tropical Medicine, Communicable Disease Prevention and Control (Tuberculosis, HIV/AIDS,
Vaccine Preventable Diseases), Heath Economics, Policy and Management

Long-term overseas experiences

Aug 2018-
Feb 2022        
Technical Advisor, Infectious Disease Control and Laboratory Services: COVID-19, AMR, TB and HIV/AIDS, the Ministry of Health and Sports, Myanmar (dispatched through JICA)
Oct 2015-
Mar 2018
Technical Officer, TB, HIV/AIDS, Hepatitis and Sexually Transmitted Diseases,  WHO Papua New Guinea
Jan 2010-
Mar 2013
Chief Advisor, the Project for scaling-up of HIV/AIDS care and management,
the Ministry of Health, Zambia (dispatched through JICA)

International committee membership


Technical Review Panel (TRP) of the Global Fund to Fight AIDS, Tuberculosis and Malaria  (2021- Focal Point of TB Expert Team)

Regional validation expert member of Elimination of Mother-to-Child Transmission (EMTCT) of HIVand Syphilis in Malaysia: WHO, Western Pacific Regional Office

Vice-Chair/Expert(Tuberculosis and HIV),The Technical Review Panel(TRP),The Global Fund

Publication list

■Journal articles

  1. Miyano S, Vynnycky E, Pattamavone C, Ichimura Y, Mori Y, Nouanthong P, et al. Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: impacts of the National Immunization Program. Int J Infect Dis. 2023. Epub 20230207. doi: 10.1016/j.ijid.2023.01.044. PubMed PMID: 36758852.
  2. Miyano S, Pathammavong C, Ichimura Y, Sugiyama M, Phounphenghack K, Tengbriacheu C, et al. Prevalence of hepatitis B and C virus infections in Lao People's Democratic Republic: The first national population-based cross-sectional survey. PLoS One. 2022;17(12):e0278933. Epub 20221230. doi: 10.1371/journal.pone.0278933. PubMed PMID: 36584043; PubMed Central PMCID: PMCPMC9803141.
  3. Miyano S, Htoon TT, Nozaki I, Pe EH, Tin HH. Public knowledge, practices, and awareness of antibiotics and antibiotic resistance in Myanmar: The first national mobile phone panel survey. PloS ONE 2022, 17(8): e027338
  4. Miyano S, Syakantu S, Komada K, et al. Cost-effectiveness analysis of the national decentralisation policy of the antiretroviral treatment programme in Zambia. BMC Cost Eff Resour Alloc 2017, 15:4.
  5. Miyano S, Muvuma S, Ishikawa N, et al. Healthcare provision for patients infected with both HIV and tuberculosis in rural Zambia: an observational cohort study of primary care centres. BMC Health Services Research 2013, 13:397.
  6. Miyano S, Dube C, Kayama N, et al. Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia. Int J Tuberc Lung Dis 2013, 17(4):540-5.
  7. Miyano S, Izumi S, Takeda Y, et al. Pulmonary tumour thrombotic microangiopathy. J Clin Oncol 2007, 25:597-9.
  8. Ichimura Y, Yamauchi M, Yoshida N, Miyano S, Komada K, Thandar MM, et al. Effectiveness of immunization activities on measles and rubella immunity among individuals in East Sepik, Papua New Guinea: A cross-sectional study. IJID Reg. 2022; 3:84-8. Epub 20220303. Doi: 10.1016/j.ijregi.2022.03.001. PubMed PMID: 35755474
  9. Kitamura T, Bouakhasith V, Miyano S, et al. Vaccine temperature management in Lao People’s Democratic Republic: A nationwide cross-sectional study. HELIYON,
  10. Nozaki I and Miyano S. The necessity of continuous international cooperation for establishing the COVID-19 diagnostic capacity despite the challenges of fighting the outbreak in home countries. Glob Health Med. 2020 Apr 30;2(2):145-147
  11. Vynnycky E, Miyano S, Komase K, et al. Estimating the immunogenicity of measles-rubella vaccination administered during a mass campaign in Lao People’s Democratic Republic using multivalent seroprevalence data. Nature Scientific Reports 2019, 9, 12545.
  12. Okabayashi H, Miyano S, Hachiya M, et al. Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey. BMC Res Notes. 2019 Mar 19;12(1):155.
  13. Hachiya M, Miyano S, Mori Y, et al. Evaluation of nationwide supplementary immunisation in Lao PDR: population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and stability testing of the vaccine. PLoS ONE 2018, 13(3):e0194931.
  14. Okawa S, Chirwa M, Miyano S, et al. Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia. BMC Pregnancy and Childbirth 2015, 15:258.
  15. Ishikawa N, Shimbo T, Miyano S, et al. Health outcomes and cost impact of the new WHO 2013 guidelines for prevention of mother-to-child transmission of HIV in Zambia. PLoS ONE 2014, 9(3).
  16. Sasaki Y, Kakimoto K, Miyano S, et al. Adherence to antiretroviral therapy (ART) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients. Ann Clin Microbiol Antimicrob 2012, 11(1):34-9.
  17. Ishikawa N, Miyano S, Sikazwe I. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN046): a randomised, double-blind, placebo-controlled trial. Lancet 2012, 379(9828):1787-8.
  18. Ishikawa N, Shimbo T, Miyano S. Costing Tool for Elimination Initiative (CTEI) From costing to planning: a tool to support the initiative for elimination of new paediatric HIV infections and congenital syphilis and improvement of the health and survival of mothers and infants. National Centre for Global Health and Medicine (NCGM), Asia-Pacific United Nations Task Force for the Prevention of Parents-to-Child Transmission of HIV, and Pan American Health Organization (PAHO), 2011.
  19. Ito K, Kubota K, Miyano S, et al. FDG-PET/CT finding of high uptake in pulmonary alveolar microlithiasis. Ann Nucl Med 2007, 21: 415-418.